Hydromorphone Hydrochloride · #5 of 35 active shortages by FDA posting duration
Brand: HYDROMORPHONE HYDROCHLORIDE
FDA lists Hydromorphone Hydrochloride as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Limited Availability
Hydromorphone Hydrochloride Injection: Active Shortage
Limited Availability 26 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydromorphone Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)
- Package NDC
- 0409-1805-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Nov 1, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay
Full Drug Profile
hydromorphone
Side effects, interactions, warnings & more
Nearby, Other Hydromorphone Shortage Records
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
FDA reason on file: Limited Supply Available. General shortage guidance lives on the tracker hub.